Gilead Sciences, Inc. (GILD)

Gilead Sciences, Inc. (GILD) scores 50 out of 100 (around average among 99 US stocks) on trend, risk, fundamentals, market backdrop and news tone. Every calculation step shown. Educational, not advice.

• Trend: 79/100
• Risk: 23/100
• Fundamentals: 16/100
• Backdrop: 45/100
• News: 87/100

GILD scores 49.9 out of 100 (around average), down 3.4 points from last week. Its news tone adds the most (+7.3 points: average FinBERT sentiment +0.493 over 14 articles). Its fundamentals weigh on it most (-6.8 points: revenue growth vs a year earlier: +7.4%). Our research found no proven record of these factors predicting returns.

Sector: Health care. Data as of 2026-10-19.